Sinotherapeutics, Inc. Class A · SSE:688247

Sinotherapeutics, Inc. Class A financial statements

Sinotherapeutics, Inc. Class A's income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in CNY

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020
Revenue446.6M511.6M299.9M247.6M315.5M319.2M
Cost of revenue270.5M247.5M132.3M71.2M69.0M59.0M
Gross profit176.0M264.2M167.6M176.3M246.5M260.2M
Research and development74.9M84.9M74.0M76.0M103.6M75.8M
Selling, general and administrative14.9M17.1M14.0M10.4M20.3M30.6M
Operating income61.5M127.8M52.7M67.5M120.3M131.8M
Depreciation and amortization31.9M24.8M23.3M26.4M26.9M22.1M
EBITDA93.4M152.6M75.9M94.0M147.2M154.0M
Interest expense1.41K2.55K37.8K213.5K229.7K
Income before tax53.3M142.1M66.0M97.5M149.0M142.3M
Net income47.5M127.7M61.1M92.9M134.9M123.3M
Earnings per share, basic0.100.280.130.200.330.30

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020
Cash and equivalents407.1M225.8M641.8M763.1M511.7M434.2M
Short-term investments339.3M507.7M
Receivables80.0M103.5M65.9M64.3M40.4M26.4M
Inventory72.5M102.4M84.6M29.4M40.4M41.8M
Current assets934.9M976.3M952.0M953.7M618.8M545.9M
Goodwill16.2M18.4M18.4M18.4M
Total assets1.44B1.45B1.36B1.33B865.8M743.1M
Accounts payable25.9M20.7M14.5M9.16M8.01M7.16M
Current liabilities83.0M103.2M90.7M90.1M89.5M143.2M
Total liabilities146.1M180.3M151.4M155.1M160.6M180.8M
Shareholders' equity1.29B1.27B1.21B1.18B705.2M562.4M
Shares outstanding453.3M453.3M453.3M453.3M408.0M408.0M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cash from operations95.3M130.2M13.0M73.2M145.8M210.0M
Capital spending-41.6M-94.9M-39.0M-176.3M-16.0M-38.3M0
Free cash flow53.8M35.3M-26.0M-103.2M129.8M171.7M
Dividends paid-27.8M-27.9M-28.1M
Change in cash181.1M-416.0M-121.4M251.5M77.7M175.9M